Cowden Syndrome

Seminars in Oncology

Volumn 34, Issue 5, 2007, Pages 428-434

  Gustafson, Shanna ^a   Zbuk, Kevin M ^a   Scacheri, Cheryl ^a   Eng, Charis ^a,b,c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B INHIBITOR; RAPAMYCIN;

ARTICLE; BANNAYAN RILEY RUVALCABA SYNDROME; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER RISK; CANCER SCREENING; CANCER SUSCEPTIBILITY; CHEMOPROPHYLAXIS; CLINICAL FEATURE; COWDEN SYNDROME; DNA DETERMINATION; ENDOMETRIUM CANCER; GENE MUTATION; GENETIC COUNSELING; HAMARTOMA TUMOR SYNDROME; HEALTH CARE PERSONNEL; HIGH RISK PATIENT; HUMAN; MULTIPLE CANCER; PHENOTYPE; PHYSICIAN; PRIORITY JOURNAL; PROTEUS LIKE SYNDROME; PTEN GENE; THYROID CANCER; THYROIDECTOMY; TUMOR SUPPRESSOR GENE;

GERM-LINE MUTATION; HAMARTOMA SYNDROME, MULTIPLE; HUMANS; PROTEUS SYNDROME; PTEN PHOSPHOHYDROLASE; SYNDROME;

EID: 34848925445     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2007.07.009     Document Type: Article

References (40)

1. Nelen M.R., Padberg G.W., Peeters E.A.J., et al. Localization of the gene for Cowden disease to 10q22-23. Nature Genet 13 (1996) 114-116
2. Waite K.A., and Eng C. Protean PTEN: Form and function. Am J Hum Genet 70 (2002) 829-844
3. Eng C. PTEN: One gene, many syndromes. Hum Mutat 22 (2003) 183-198
4. Pilarski R., and Eng C. Will the real Cowden syndrome please stand up (again)?. Expanding mutational and clinical spectra of the PTEN hamartoma tumour syndrome. J Med Genet 41 (2004) 323-326
5. Gorlin R.J., Cohen M.M., Condon L.M., et al. Banayan-Riley-Rvalcabe sydrome. Am J Med Genet 44 (1992) 307-314
6. Biesecker L.G., Happle R., Mulliken J.B., et al. Proteus syndrome: Diagnostic criteria, differential diagnosis and patient evaluation. Am J Med Genet 84 (1999) 389-395
7. Nelen M.R., Kremer H., Konings I.B., et al. Novel PTEN mutations in patients with Cowden disease: Absence of clear genotype-phenotype correlations. Eur J Hum Genet 7 (1999) 267-273
8. Eng C., and Parsons R. Cowden syndrome. In: Vogelstein B., and Kinzler K.W. (Eds). The Genetic Basis of Human Cancer (1998), McGraw-Hill, New York 519-526
9. Marsh D.J., Coulon V., Lunetta K.L., et al. Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum Mol Genet 7 (1998) 507-515
10. Eng C. Cowden syndrome. J Genet Counsel 6 (1997) 181-191
11. Longy M., and Lacombe D. Cowden disease. Report of a family and review. Ann Genet 39 (1996) 35-42
12. Fackenthal J.D., Marsh D.J., Richardson A.L., et al. Male breast cancer in Cowden syndrome patients with germline PTEN mutations. J Med Genet 38 (2001) 159-164
13. Schrager C.A., Schneider D., Gruener A.C., et al. Clinical and pathological features of breast disease in Cowden's syndrome: An underrecognised syndrome with an increased risk of breast cancer. Hum Pathol 29 (1997) 47-53
14. Reifenberger J., Rauch L., Beckmann M.W., et al. Cowden's disease: Clinical and molecular genetic findings in a patient with a novel PTEN germline mutation. Br J Dermatol 148 (2003) 1040-1046
15. Metcalfe K., Lynch H.T., Ghadirian P., et al. Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. J Clin Oncol 22 (2004) 2328-235
16. Pilarski R., and Eng C. Will the real Cowden syndrome please stand up (again)?Expanding mutational and clinical spectra of the PTEN hamartoma tumour syndrome. J Med Genet 41 (2004) 323-326
17. Marsh D.J., Dahia P.L., Caron S., et al. Germline PTEN mutations in Cowden syndrome-like families. J Med Genet 35 (1998) 881-885
18. Eng C. Will the real Cowden syndrome please stand up: Revised diagnostic criteria. J Med Genet 37 (2000) 828-830
19. Mallory S.B. Cowden syndrome (multiple hamartoma syndrome). Dermatol Clin 13 (1995) 27-31
20. Starink T.M., van der Veen J.P., Arwert F., et al. The Cowden syndrome: A clinical and genetic study in 21 patients. Clin Genet 29 (1986) 222-233
21. Harach H., Soubeyran I., Brown A., et al. Thyroid pathologic findings in patients with Cowden disease. Ann Diagn Pathol 3 (1999) 331-340
22. Hanssen A.M.N., and Fryns J.P. Cowden syndrome. J Med Genet 32 (1995) 117-119
23. Sweet K., Willis J., Zhou X.P., et al. Molecular classification of patients with unexplained hamartomatous and hyperplastic polyposis. JAMA 294 (2005) 2465-2473
24. Kay P.S., Soetikno R.M., Mindelzun R., et al. Diffuse esophageal glycogenic acanthosis: An endoscopic marker of Cowden's disease. Am J Gastroenterol 92 (1997) 1038-1040
25. Weber H.C., Marsh D., Lubensky I., et al. Germline PTEN/MMAC1/TEP1 mutations and association with gastrointestinal manifestations in Cowden disease. Gastroenterology 114S (1998) G2902
26. Ambler M., Pogacar S., and Sidman R. Lhermitte-Duclos disease (granule cell hypertrophy of the cerebellum). Pathologic analysis of the first familial cases. J Neuropathol Exp Neurol 28 (1969) 622-647
27. Rebbeck T.R., Friebel T., Lynch H.T., et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: The PROSE Study Group. J Clin Oncol 22 (2004) 1055-1062
28. Fujio Y., Nguyen T., Wencker D., et al. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation 101 (2000) 660-667
29. Zdychova J., and Komers R. Emerging role of Akt kinase/protein kinase B signaling in pathophysiology of diabetes and its complications. Physiol Res 54 (2005) 1-16
30. Sausville E.A., Arbuck S.G., Messmann R., et al. Phase I trial of 72-hour continuous infusion UCN-01 in patients with refractory neoplasms. J Clin Oncol 19 (2001) 2319-2333
31. Marsh D.J., Kum J.B., Lunetta K.L., et al. PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome. Hum Mol Genet 8 (1999) 1461-1472
32. Hachicha M., Kammoun T., Chabchoub I., et al. Cowden's disease: A new paediatric observation. Arch Pediatr 13 (2006) 459-462
33. Liaw D., Marsh D.J., Li J., et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16 (1997) 64-67
34. Zhou X.P., Waite K.A., Pilarski R., et al. Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway. Am J Hum Genet 73 (2003) 404-411
35. Tamura M., Gu J., Danen E.H.J., et al. PTEN interactions with focal adhesion kinase and suppression of the extracellular matrix-dependent phosphotidyinositol 3-kinase/Akt cell survival pathway. J Biol Chem 274 (1999) 20693-20703
36. Weng L.P., Brown J.L., and Eng C. PTEN coordinates G1 arrest by down regulating cyclin D1 via its protein phosphatase activity and up regulating p27 via its lipid phosphatase activity. Hum Mol Genet 10 (2001) 599-604
37. Stambolic V., Suzuki A., de la Pompa J.L., et al. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95 (1998) 29-39
38. Li D.M., and Sun H. PTEN/MMAC1/TEP1 suppresses the tumorigenecity and induces G1 cell cycle arrest in human glioblastoma cells. Proc Natl Acad Sci U S A 95 (1998) 15406-15411
39. Di Cristofano A., Kotsi P., Peng Y.F., et al. Impaired Fas response and autoimmunity in Pten+/- mice. Science 285 (1999) 2122-2125
40. Chung J.H., and Eng C. Nuclear-cytoplasmic partitioning of phosphatase and tensin homologue deleted on chromosome 10 (PTEN) differentially regulates the cell cycle and apoptosis. Cancer Res 65 (2005) 8096-8100